These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Guidelines for the management of Parkinson's disease. The Parkinson's Disease Consensus Working Group. Bhatia K; Brooks DJ; Burn DJ; Clarke CE; Playfer J; Sawle GV; Schapira AH; Stewart D; Williams AC Hosp Med; 1998 Jun; 59(6):469-80. PubMed ID: 9775275 [TBL] [Abstract][Full Text] [Related]
7. Recent advances in Parkinson's disease therapy: use of monoamine oxidase inhibitors. Henchcliffe C; Schumacher HC; Burgut FT Expert Rev Neurother; 2005 Nov; 5(6):811-21. PubMed ID: 16274338 [TBL] [Abstract][Full Text] [Related]
8. Identifying poor symptom control in Parkinson's disease. Scott L Nurs Times; 2006 Mar 21-27; 102(12):30-2. PubMed ID: 16594560 [TBL] [Abstract][Full Text] [Related]
9. New drugs in the future treatment of Parkinson's disease. Djaldetti R; Melamed E J Neurol; 2002 Sep; 249 Suppl 2():II30-5. PubMed ID: 12375061 [TBL] [Abstract][Full Text] [Related]
11. [Current pharmacotherapy of Parkinson's disease]. Takáts A Orv Hetil; 2000 Mar; 141(10):483-8. PubMed ID: 10750400 [TBL] [Abstract][Full Text] [Related]
12. Comprehensive review of rasagiline, a second-generation monoamine oxidase inhibitor, for the treatment of Parkinson's disease. Chen JJ; Swope DM; Dashtipour K Clin Ther; 2007 Sep; 29(9):1825-49. PubMed ID: 18035186 [TBL] [Abstract][Full Text] [Related]
13. Parkinson's disease. Therapeutic strategies to improve patient function and quality of life. Danisi F Geriatrics; 2002 Mar; 57(3):46-50; quiz 52. PubMed ID: 11899548 [TBL] [Abstract][Full Text] [Related]
14. Parkinson's disease therapy: treatment of early and late disease. Jankovic J Chin Med J (Engl); 2001 Mar; 114(3):227-34. PubMed ID: 11780303 [TBL] [Abstract][Full Text] [Related]
15. Relating mode of action to clinical practice: dopaminergic agents in Parkinson's disease. Riederer P; Gerlach M; Müller T; Reichmann H Parkinsonism Relat Disord; 2007 Dec; 13(8):466-79. PubMed ID: 17919963 [TBL] [Abstract][Full Text] [Related]
16. Parkinson's disease: making the diagnosis, selecting drug therapies. Scharre DW; Mahler ME Geriatrics; 1994 Oct; 49(10):14-6, 20-3. PubMed ID: 7926845 [TBL] [Abstract][Full Text] [Related]
17. Selegiline: a second look. Six years later: too risky in Parkinson's disease. Prescrire Int; 2002 Aug; 11(60):108-11. PubMed ID: 12199263 [TBL] [Abstract][Full Text] [Related]
18. Novel pharmacological targets for the treatment of Parkinson's disease. Schapira AH; Bezard E; Brotchie J; Calon F; Collingridge GL; Ferger B; Hengerer B; Hirsch E; Jenner P; Le Novère N; Obeso JA; Schwarzschild MA; Spampinato U; Davidai G Nat Rev Drug Discov; 2006 Oct; 5(10):845-54. PubMed ID: 17016425 [TBL] [Abstract][Full Text] [Related]
19. [Drug therapy in Parkinson's disease]. van Hilten JJ; Roos RA Ned Tijdschr Geneeskd; 1999 Jan; 143(5):234-40. PubMed ID: 10086151 [TBL] [Abstract][Full Text] [Related]